Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC

被引：45
|
作者：
Risiglione, Pierpaolo [1 ]
Zinghirino, Federica [1 ]
Di Rosa, Maria Carmela [1 ]
Magri, Andrea [2 ,3 ]
Messina, Angela [2 ,3 ]
机构：
[1] Univ Catania, Dept Biomed & Biotechnol Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[2] Univ Catania, Dept Biol Geol & Environm Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[3] WeMitoBiotech SRL, C So Italia 172, I-95125 Catania, Italy
来源：
BIOMOLECULES | 2021年 / 11卷 / 05期
关键词：
Alpha-Synuclein; mitochondria; VDAC; Parkinson's disease; mitochondrial dysfunction; DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; BCL-2 FAMILY PROTEINS; COMPLEX-I DEFICIENCY; OXIDATIVE STRESS; HEXOKINASE-I; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; SUPEROXIDE-PRODUCTION; OLIGOMERS INTERACT;
D O I：
10.3390/biom11050718
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Alpha-Synuclein (alpha Syn) is a protein whose function is still debated, as well as its role in modulation of mitochondrial function in both physiological and pathological conditions. Mitochondrial porins or Voltage-Dependent Anion Channel (VDAC) proteins are the main gates for ADP/ATP and various substrates towards the organelle. Furthermore, they act as a mitochondrial hub for many cytosolic proteins, including alpha Syn. This review analyzes the main aspects of alpha Syn-mitochondria interaction, focusing on the role of VDAC and its emerging involvement in the pathological processes.
引用
收藏
页数：19
相关论文
共 50 条
  • [31] Alpha-synuclein and the prion hypothesis in Parkinson's disease
    Melki, R.
    REVUE NEUROLOGIQUE, 2018, 174 (09) : 644 - 652
  • [32] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
  • [33] Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
    Rohn, Troy T.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 174 - 179
  • [34] Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease
    Ma, Ling-Yan
    Liu, Gen-Liang
    Wang, Dong-Xu
    Zhang, Mei-Mei
    Kou, Wen-Yi
    Feng, Tao
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 812 - 823
  • [35] The Role of Alpha-Synuclein Deposits in Parkinson's Disease: A Focus on the Human Retina
    Di Pippo, Mariachiara
    Fragiotta, Serena
    Di Staso, Federico
    Scuderi, Luca
    Abdolrahimzadeh, Solmaz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [36] Alpha-Synuclein and Oxidative Stress Enzymes as Biomarkers of Parkinson's Disease
    Goncharova, Z. A.
    Kolmakova, T. S.
    Gelpei, M. A.
    NEUROCHEMICAL JOURNAL, 2017, 11 (02) : 121 - 128
  • [37] Parkinson's Disease: A Nanotheranostic Approach Targeting Alpha-Synuclein Aggregation
    Zoey, Fong LaiGuan
    Palanivel, Mathangi
    Padmanabhan, Parasuraman
    Gulyas, Balazs
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [38] Alpha-synuclein and oxidative stress enzymes as biomarkers of Parkinson’s disease
    Z. A. Goncharova
    T. S. Kolmakova
    M. A. Gelpei
    Neurochemical Journal, 2017, 11 : 121 - 128
  • [39] Loss of Functional Alpha-Synuclein: A Toxic Event in Parkinson's Disease?
    Kanaan, Nicholas M.
    Manfredsson, Fredric P.
    JOURNAL OF PARKINSONS DISEASE, 2012, 2 (04) : 249 - 267
  • [40] Alpha-Synuclein as a Mediator in the Interplay between Aging and Parkinson's Disease
    Bobela, Wojciech
    Aebischer, Patrick
    Schneider, Bernard Laurent
    BIOMOLECULES, 2015, 5 (04): : 2675 - 2700
12345